5-FU | 5-fluorouracil |
ADCs | antibody-drug conjugates |
BRAF CEP17 |
v-raf murine sarcoma viral oncogene homolog B1 centromere enumeration probe for chromosome 17 |
CNS | central nervous system |
CRC | colorectal cancer |
ctDNA | circulating tumor DNA |
EGF EGFR EREG |
epidermal growth factor epidermal growth factor receptor epiregulin |
ESMO | European Society of Medical Oncology |
FISH | fluorescence in situ hybridization |
FOLFIRI | 5-fluouracil/leucovorin/irinotecan |
FOLFOX | 5-fluouracil/leucovorin/oxaliplatin |
FOLFOXIRI | 5-fluouracil/leucovorin/oxaliplatin/irinotecan |
HER2 | human epidermal growth factor receptor 2 |
IHC | immunochemistry |
LV | leucovorin |
m MAPK |
month mitogen-activated protein kinase |
mCRC | metastatic colorectal cancer |
mPFS | median progression-free survival |
NCCN | National Comprehensive Cancer Network |
NGS | next-generation sequencing |
NK | natural killer |
NTRK | neurotrophic tyrosine receptor kinase |
ORR | overall response rates |
OS PI3K |
overall survival phosphoinositide 3-kinase |
PFS PTEN |
progression-free survival phosphatase and tensin homolog |
QT | chemotherapy |
RAS RTK STAT |
rat sarcoma virus receptor tyrosine kinase signal transducer and activator of transcription |
T-DM1 | trastuzumab emastine |
TD | trastuzumab deruxtecan |
TKIs | tyrosine kinase inhibitors |
VEGF | anti-vascular endothelial growth factor |
WT | wild-type |